tiprankstipranks
Trending News
More News >
Inspire Veterinary Partners, Inc. Class A (IVP)
:IVP
US Market

Inspire Veterinary Partners, Inc. Class A (IVP) AI Stock Analysis

Compare
413 Followers

Top Page

IV

Inspire Veterinary Partners, Inc. Class A

(NASDAQ:IVP)

Rating:41Neutral
Price Target:
$1.50
▲(4.17%Upside)
The overall stock score is heavily impacted by financial performance issues, including high leverage and negative income. Technical analysis also indicates weak momentum. Despite a positive corporate acquisition, the lack of profitability and valuation concerns result in a low overall score.

Inspire Veterinary Partners, Inc. Class A (IVP) vs. SPDR S&P 500 ETF (SPY)

Inspire Veterinary Partners, Inc. Class A Business Overview & Revenue Model

Company DescriptionInspire Veterinary Partners, Inc. owns and operates veterinary hospitals in the United States. The company specializes in small animal general practice hospitals, which serve companion pets, canine, and feline breeds. Its hospitals provide preventive care for companion animals consisting of annual health exams and parasite control; dental health; nutrition and body condition counseling; neurological examinations; radiology; bloodwork; and skin and coat health, and other breed specific preventive care services. The company also provides surgical services, which include soft tissue procedures, such as spays and neuters, mass removals, splenectomies, gastropexies, orthopedic procedures, and other surgical offerings; and care and alternative procedures, such as acupuncture, chiropractic, and other health and wellness services. Inspire Veterinary Partners, Inc. was incorporated in 2020 and is based in Virginia Beach, Virginia.
How the Company Makes MoneyInspire Veterinary Partners, Inc. makes money primarily through the provision of veterinary services at its network of clinics. Revenue is generated from fees charged for medical consultations, diagnostic tests, surgical procedures, and preventive care services such as vaccinations and wellness exams. Additionally, the company may earn income through the sale of pet-related products, including prescription medications, pet food, and wellness products. Significant partnerships with pet insurance providers and pet product manufacturers could also contribute to its earnings by facilitating access to a broader customer base or offering exclusive services and products.

Inspire Veterinary Partners, Inc. Class A Financial Statement Overview

Summary
Inspire Veterinary Partners, Inc. is facing significant financial challenges with consistent net losses, high leverage, and negative free cash flow. These factors indicate potential risks in terms of liquidity and financial stability, requiring strategic actions to improve profitability and cash flow management.
Income Statement
35
Negative
Inspire Veterinary Partners, Inc. has seen fluctuating revenues with a recent decline in total revenue during TTM. Gross profit margins have been weak, and the company continues to operate at a net loss, indicating challenges in achieving profitability. The negative EBIT and EBITDA margins further highlight ongoing operational inefficiencies and cost management issues.
Balance Sheet
30
Negative
The company has a high debt-to-equity ratio, reflecting significant leverage which poses financial risk. Stockholders’ equity remains low, resulting in a low equity ratio. Negative equity in previous years indicates potential financial instability, although there has been some improvement as of the latest TTM data.
Cash Flow
40
Negative
Inspire Veterinary Partners, Inc. has experienced negative free cash flow, indicating challenges in generating sufficient cash from operations to cover capital expenditures. The operating cash flow to net income ratio is unfavorable due to consistent net losses, reflecting ongoing cash flow struggles.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue15.40M16.59M16.68M9.83M2.55M0.00
Gross Profit2.90M6.86M3.55M2.55M829.29K0.00
EBITDA-8.69M-9.50M-10.84M-2.91M-977.46K0.00
Net Income-13.26M-14.26M-14.79M-4.91M-1.33M-5.52K
Balance Sheet
Total Assets20.66M20.20M21.79M20.19M6.33M21.97K
Cash, Cash Equivalents and Short-Term Investments1.74M523.69K178.96K444.25K2.06M21.97K
Total Debt15.24M16.37M18.42M23.61M6.69M0.00
Total Liabilities17.66M18.63M22.58M25.32M7.20M0.00
Stockholders Equity3.00M1.56M-788.26K-5.14M-869.09K21.97K
Cash Flow
Free Cash Flow-8.31M-10.24M-4.20M-2.84M-2.32M-5.52K
Operating Cash Flow-8.21M-10.01M-3.82M-2.66M-1.01M-5.52K
Investing Cash Flow-101.31K-238.00K-1.87M-14.67M-4.02M0.00
Financing Cash Flow9.90M10.59M5.63M15.71M7.07M269.16K

Inspire Veterinary Partners, Inc. Class A Technical Analysis

Technical Analysis Sentiment
Negative
Last Price1.44
Price Trends
50DMA
1.61
Negative
100DMA
1.71
Negative
200DMA
4.15
Negative
Market Momentum
MACD
-0.03
Positive
RSI
39.96
Neutral
STOCH
6.40
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IVP, the sentiment is Negative. The current price of 1.44 is below the 20-day moving average (MA) of 1.67, below the 50-day MA of 1.61, and below the 200-day MA of 4.15, indicating a bearish trend. The MACD of -0.03 indicates Positive momentum. The RSI at 39.96 is Neutral, neither overbought nor oversold. The STOCH value of 6.40 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IVP.

Inspire Veterinary Partners, Inc. Class A Risk Analysis

Inspire Veterinary Partners, Inc. Class A disclosed 48 risk factors in its most recent earnings report. Inspire Veterinary Partners, Inc. Class A reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Inspire Veterinary Partners, Inc. Class A Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
JXJXG
63
Neutral
$6.55M0.7617.05%56.53%10.88%
62
Neutral
$16.90B11.24-7.48%2.95%1.60%-23.76%
52
Neutral
$5.86M-37.82%-16.89%31.24%
46
Neutral
$4.92M-54.97%-57.48%-27.43%
44
Neutral
$7.60M-80.86%-55.43%55.17%
44
Neutral
$4.31M-28.60%
IVIVP
41
Neutral
$7.40M-809.91%-10.59%99.33%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IVP
Inspire Veterinary Partners, Inc. Class A
1.44
-72.81
-98.06%
JXG
JX Luxventure
1.62
-4.18
-72.07%
VMAR
Vision Marine Technologies
6.87
-614.27
-98.89%
JWEL
Jowell Global
2.70
0.70
35.00%
VEEE
Twin Vee PowerCats
2.20
-2.80
-56.00%
CTNT
Cheetah Net Supply Chain Service, Inc. Class A
1.34
-5.47
-80.32%

Inspire Veterinary Partners, Inc. Class A Corporate Events

M&A Transactions
Inspire Veterinary Partners Acquires Debary Animal Clinic
Positive
Jun 10, 2025

On June 5, 2025, Inspire Veterinary Partners, Inc. completed the acquisition of Debary Animal Clinic and its related real estate assets in Florida, marking its fifth acquisition in the state. This acquisition is expected to add approximately $1.8 million in annual revenue and increase the company’s network of animal hospitals to 14, enhancing its presence in the Florida pet care market.

Private Placements and Financing
Inspire Veterinary Partners Issues Discount Notes for Capital
Neutral
Jun 5, 2025

On May 30, 2025, Inspire Veterinary Partners, Inc. issued Original Issue Discount Notes to 1800 Diagonal Lending LLC and Boot Capital LLC, with principal amounts of $204,700 and $92,000 respectively, to be used for general working capital. These notes, which mature on March 30, 2026, include provisions for interest payments and allow the lenders to convert the debt into shares of the company’s common stock under certain conditions, impacting the company’s financial strategy and stakeholder interests.

Executive/Board Changes
Inspire Veterinary Partners Secures CEO Employment Agreement
Neutral
Apr 23, 2025

Inspire Veterinary Partners, Inc. has formalized an employment agreement with its current CEO, Kimball Carr, for an initial two-year term. The agreement outlines Mr. Carr’s responsibilities, compensation, and conditions for termination, aiming to ensure his full commitment to the company’s interests. The contract includes a base salary, performance bonuses, potential stock awards, and non-disclosure provisions, while also detailing circumstances under which either party may terminate the agreement.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 02, 2025